BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29992674)

  • 1. The effects of state-level pharmacist regulations on generic substitution of prescription drugs.
    Song Y; Barthold D
    Health Econ; 2018 Nov; 27(11):1717-1737. PubMed ID: 29992674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.
    Sacks CA; Van de Wiele VL; Fulchino LA; Patel L; Kesselheim AS; Sarpatwari A
    JAMA Intern Med; 2021 Jan; 181(1):16-22. PubMed ID: 32865564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State Laws and Generic Substitution in the Year After New Generic Competition.
    Rome BN; Sarpatwari A; Kesselheim AS
    Value Health; 2022 Oct; 25(10):1736-1742. PubMed ID: 35487821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and Practices.
    Sarpatwari A; Lee MP; Gagne JJ; Lu Z; Dutcher SK; Jiang W; Campbell EG; Kesselheim AS
    Clin Pharmacol Ther; 2018 Jun; 103(6):1093-1099. PubMed ID: 29165800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin.
    Olsson E; Kälvemark Sporrong S
    Int J Pharm Pract; 2012 Dec; 20(6):377-83. PubMed ID: 23134096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS; Phillips KA; Gerstenberger EP; Seger AC
    Ann Intern Med; 2005 Jun; 142(11):891-7. PubMed ID: 15941695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State generic substitution laws can lower drug outlays under Medicaid.
    Shrank WH; Choudhry NK; Agnew-Blais J; Federman AD; Liberman JN; Liu J; Kesselheim AS; Brookhart MA; Fischer MA
    Health Aff (Millwood); 2010 Jul; 29(7):1383-90. PubMed ID: 20606192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program.
    Ma I; Tisdale RL; Vail D; Heidenreich PA; Sandhu AT
    Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007559. PubMed ID: 34879702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing generic and branded substitution patterns in the Netherlands using prescription data.
    Pechlivanoglou P; van der Veen WJ; Bos JH; Postma MJ
    BMC Health Serv Res; 2011 Apr; 11():89. PubMed ID: 21524312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged.
    Levy MS
    Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
    JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs.
    Darrow JJ; Chong JE; Kesselheim AS
    BMJ; 2020 Jun; 369():m2236. PubMed ID: 32576554
    [No Abstract]   [Full Text] [Related]  

  • 16. Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon.
    Saleh S; Abou Samra C; Jleilaty S; Constantin J; El Arnaout N; Dimassi H; Al-Bittar D
    Int J Clin Pharm; 2017 Oct; 39(5):1101-1109. PubMed ID: 28823020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia.
    Ping CC; Bahari MB; Hassali MA
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):82-9. PubMed ID: 17879323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of generic substitution in community pharmacies.
    Suh DC
    Pharm World Sci; 1999 Dec; 21(6):260-5. PubMed ID: 10658234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Potential savings with substitution of generic drugs for brand-name drugs.
    Ann Intern Med; 2005 Jun; 142(11):I30. PubMed ID: 15941691
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of pharmacists' opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic.
    Maly J; Dosedel M; Kubena A; Vlcek J
    Acta Pol Pharm; 2013; 70(5):923-31. PubMed ID: 24147373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.